InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.67
(
0.00%
)
US TECH 100
17,587.60
(
-0.14%
)
Dow Jones
39,056.39
(
0.44%
)
Brent Oil
83.56
(
0.84%
)
Bitcoin
61,029.39
(
-2.09%
)
Post# of 4871
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: None

Monday, 10/05/2015 4:20:47 PM

Monday, October 05, 2015 4:20:47 PM

Post# of 4871
Alliqua (ALQA) Snapshot

Key Strengths
Strong revenue growth (+250% in 2015e) from internal, partnered and acquired products (expecting guidance to be raised at 3Q15 conf call)
Increasing margins (approaching 70% on internal products) reflects the continued shift away from historic contract mfr business
Improved balance sheet (recently raised ~$30M at $4.55)
Partner Validation (Celgene has a 15% equity position and both their CMO and Head of CELG Cellular therapeutics sit on the BoD)

Continued on Biotech Values
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up